Hospinova SRL
Hospinova reported total assets of 509,654 € at the end of the 2025 financial year (annual accounts filed with the NBB on 12 Jun 2026).
The score of Hospinova shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +188 % Total assets +27 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hospinova's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 197,706 € | ||||
| Equity | 90,567 € | ||||
| Cash | 129,390 € | ||||
| EBITDA | 282,672 € | ||||
| Total assets | 509,654 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 Jun 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 19 Aug 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 28 Sep 2022
Hospinova's financial analysis
- Solvency17.8%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hospinova
Hospinova's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0835.268.285
- VAT number
- BE0835268285
- Peppol
- Registered · 0208:0835268285 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Apr 2011
- Registered office
- 5310 Éghezée
- Latest accounts
- 2025 · filed on 12 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Hospinova (SRL) has been based in Éghezée since 2011, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 197,706 € and equity of 90,567 €; its revenue is not published. Its solvency stands at 17.8%, below the median of its sector (43.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Hospinova
Companies in the same business, of comparable size and area, outside its group.
- Verachtert Digital Manufacture of medical and dental instruments and supplies Antwerp · balance sheet €1.08m
- Green 2 Manufacture of basic pharmaceutical products Ostend · balance sheet €2.01m
- Orthophysics Manufacture of medical and dental instruments and supplies Hooglede · balance sheet €2.78m
- Roller Wholesale of pharmaceutical and medical goods Willebroek · balance sheet 167,766 €
- Novalab Wholesale of pharmaceutical and medical goods Uccle · balance sheet 113,734 €
- Cooltube Wholesale of pharmaceutical and medical goods Kontich · balance sheet 899,612 €
- Global Health Support Wholesale of pharmaceutical and medical goods Esneux · balance sheet 201,247 €
- Ecce Medical Wholesale of pharmaceutical and medical goods Scherpenheuvel-Zichem · balance sheet 504,400 €
Frequently asked questions about Hospinova
What is the revenue of Hospinova?
Hospinova files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Hospinova?
In Belgium, the VAT number is the company number prefixed with BE: BE0835268285 for Hospinova, if the company is VAT-registered. Its company number (CBE) is 0835.268.285.
Where is the registered office of Hospinova?
According to the CBE register, the registered office of Hospinova is in 5310 Éghezée.
What is the equity of Hospinova?
At the close of the 2025 financial year, the equity of Hospinova amounts to 90,567 €, a solvency of 17.8% of total assets.
Who manages Hospinova?
The register lists 3 active mandates at Hospinova. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hospinova
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →